Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metastasis Research

Background:

• Small-cell lung cancer (SCLC) is highly aggressive with poor treatment options and frequent metastasis.
• The molecular mechanisms driving SCLC metastasis remain poorly understood.
• Estrogen-related receptor gamma (ERRγ) has emerged as a potential factor in cancer progression.

Purpose of the Study:

• To investigate the role of ERRγ in the metastasis of SCLC.
• To determine if ERRγ is a viable therapeutic target for metastatic SCLC.

Main Methods:

• Analysis of ERRγ expression in metastatic SCLC tumors.
• Investigating ERRγ's function in extracellular matrix (ECM) remodeling and cell adhesion.
• Utilizing genetic and pharmacological inhibition of ERRγ in SCLC models (cell-derived and patient-derived xenografts).
• Assessing the impact of ERRγ inhibition on tumor growth, metastasis, and chemotherapy response.

Main Results:

• ERRγ is overexpressed in metastatic SCLC and correlates with disease progression.
• ERRγ directly regulates key genes involved in ECM remodeling and cell adhesion, crucial for metastasis.
• Inhibition of ERRγ significantly reduced collagen production, cell-matrix adhesion, and microfilament production.
• ERRγ inhibition blocked SCLC cell invasion and metastasis, suppressed tumor growth, and restored chemotherapy sensitivity.

Conclusions:

• ERRγ is a critical driver of metastasis in small-cell lung cancer.
• Targeting ERRγ represents a promising therapeutic strategy for metastatic SCLC.
• ERRγ antagonists may offer a novel approach to treat this lethal malignancy and overcome treatment resistance.